BCG vaccination induces cross-protective immunity against pathogenic microorganisms

Jorge A. Soto, Nicolás M.S. Gálvez, Catalina A. Andrade, Mario A. Ramírez, Claudia A. Riedel, Alexis M. Kalergis, Susan M. Bueno

Resultado de la investigación: Contribución a una revistaArtículo de revisiónrevisión exhaustiva

4 Citas (Scopus)

Resumen

Bacillus Calmette-Guérin (BCG) is an attenuated Mycobacterium bovis strain used as a vaccine to prevent Mycobacterium tuberculosis (M. tb) infection. Its ability to potentiate the immune response induced by other vaccines and to promote nonspecific immunomodulatory effects has been described. These effects can be triggered by epigenetic reprogramming and metabolic shifts on innate immune cells, a phenomenon known as trained immunity. The induction of trained immunity may contribute to explain why BCG vaccination effectively decreases disease symptoms caused by pathogens different from M. tb. This article explains the importance of BCG immunization and the possible mechanisms associated with the induction of trained immunity, which might be used as a strategy for rapid activation of the immune system against unrelated pathogens.

Idioma originalInglés
Páginas (desde-hasta)322-335
Número de páginas14
PublicaciónTrends in Immunology
Volumen43
N.º4
DOI
EstadoPublicada - abr. 2022

Áreas temáticas de ASJC Scopus

  • Inmulogía y alergología
  • Inmunología

Huella

Profundice en los temas de investigación de 'BCG vaccination induces cross-protective immunity against pathogenic microorganisms'. En conjunto forman una huella única.

Citar esto